KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $928,000 | -1.3% | 5,163 | -43.0% | 0.11% | -16.3% |
| Q2 2017 | $940,000 | +1416.1% | 9,063 | +1051.6% | 0.14% | +1025.0% |
| Q1 2017 | $62,000 | -68.5% | 787 | -82.1% | 0.01% | -70.0% |
| Q4 2016 | $197,000 | -86.9% | 4,387 | -83.8% | 0.04% | -90.9% |
| Q3 2016 | $1,509,000 | +1455.7% | 27,018 | +1176.2% | 0.44% | +975.6% |
| Q1 2016 | $97,000 | +4750.0% | 2,117 | +5471.1% | 0.04% | +1950.0% |
| Q3 2015 | $2,000 | -98.4% | 38 | -98.2% | 0.00% | -98.7% |
| Q2 2015 | $126,000 | +44.8% | 2,072 | +38.1% | 0.15% | +2.8% |
| Q1 2015 | $87,000 | – | 1,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |